-
Fundamentals of Major Depressive Disorder Treatment in Adults, Volume 4
CME The fourth volume in this series addresses guidelines for depression treatment, comorbid depression, and substance use disorder, and the development of treatment goals.
February 2012
-
Antipsychotics May Increase Diabetes Risk in Children
CME A large retrospective study shows that children who begin taking antipsychotic drugs have an increased risk for the development of incident diabetes.
Medscape Education Clinical Briefs, November 2011
-
Major Depressive Disorder: Applying the Guidelines to Real-World Cases – Recurrent Depression and Bipolar Spectrum
CME How can you differentiate between MDD and bipolar depression? Which medications are most effective in this setting? Which are safe?
Medscape Education Psychiatry & Mental Health, November 2011
-
Myth Dispelled: Creativity Associated With Mental Illness
CME According to a Swedish study, creative people have a disproportionately higher rate of mental disorders, including schizophrenia and bipolar disorder.
Medscape Education Clinical Briefs, November 2011
-
Fundamentals of Major Depressive Disorder Treatment in Adults, Volume 2
CME Depression treatment can fail if comorbid psychiatric disorders and side effects are not addressed. Here's guidance for the busy clinician.
Medscape Education Psychiatry & Mental Health, November 2011
-
Bipolar Disorder Differences Between Genders: Special Considerations for Women
CME What particular issues should physicians consider in the evaluation and treatment of bipolar disorder among women? The current review answers this question.
Women's Health, November 2011
-
Suicide Risk Increased for All Psychiatric Disorders
CME Patients with any major psychiatric disorder are at significant risk for suicide after their first hospital visit, according to new research.
Medscape Education Clinical Briefs, October 2011
-
Bipolar Disorder May Be Unrecognized in Patients With Major Depressive Episode
CME A study suggests that many patients with a major depressive episode receive ineffective pharmacologic treatment because they have an underlying, unrecognized bipolar disorder.
Medscape Education Clinical Briefs, August 2011
-
FDA Issues Alert of Cognitive Delay in Infants Exposed to Valproate
CME/CE The FDA has issued an alert to underline the increased risk for lower cognitive test scores among children born to mothers taking the antiseizure medication valproate sodium during pregnancy.
Medscape Education Clinical Briefs, July 2011
-
Bipolar Disorder: Therapeutic Use of Omega-3 Fatty Acids
CME A review describes the role of omega-3 polyunsaturated fatty acids and brain-derived neurotrophic factor as neuroprotective, neurogenic agents that may be useful in bipolar disorder.
Expert Review of Neurotherapeutics, July 2011
-
Adult ADHD Comorbidities: A Comprehensive Self-Study Program
How does a clinician differentiate among the symptoms of ADHD and its comorbidities in order to best manage both? Four authorities lend you their expertise in this extensive program.
March 2007
-
15th European College of Neuropsychopharmacology Congress
New science and clinical understanding from ECNP.
November 2002
-
XII World Congress of Psychiatry
Selected sessions from the XII World Congress of Psychiatry, Yokohama, Japan.
September 2002
-
XXIIIrd Congress of the Collegium Internationale Neuro-Psychopharmacologicum (CINP)
Highlights from the CINP -- neuroscience meets psychiatry
July 2002
